|
Market Cap (25-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 24 November 2020, 14:42. The announcement is marked as price sensitive, and is 22 page(s) in length and 261.13kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.164% short sold according to ASIC data. It was ranked the 381st most shorted stock on the ASX. It remains ranked 426th as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Prospectus filed pursuant to SEC Rule 424(b)(3) | 24 November 2020, 14:42 |
| Appendix 3G | 24 November 2020, 13:34 |
| Appendix 2A and Section 708A(5) Cleansing Notice | 24 November 2020, 13:33 |
| Change in substantial holding | 24 November 2020, 8:23 |
You must be logged in to post a reply.
Alterity Therapeutics 